Social

Actinogen announces new and unique nonproprietary name of 'emestedastat' for Xanamem

Late-stage Alzheimer\'s trial opens 10 new sites in USA,with results due in 2025 and 2026 SYDNEY,Feb. 5,2025-- Actinogen Medical Limited (ASX: ACW) announces that the World Health Organization (WHO)

Social

Feb 7, 2025

I Peace establishes and offers low immunoreaction risk GMP iPS Cells

Three lines of GMP iPS Cells derived from type O female blood are now offeredas off-the-shelf product

Social

Feb 7, 2025

Argent BioPharma: A Hidden Gem traded Under $12M--Edison Group Report Assigned a $327M Valuation to Its Breakthrough Epilepsy Treatment

PERTH,Australia,Feb. 6,2025-- Argent BioPharma (ASX: RGT) (OTCQB: RGTLF),a clinical-stage biopharmaceutical company brings hope to epilepsy patients.

Social

Feb 7, 2025

Yum China Reports Fourth Quarter Results and Increases Dividend by 50%

Fourth Quarter Operating Profit Grew 36% and OP Margin1 Expanded 140 Basis Points Sequential Improvement in Same-Store Sales Index and Eighth Consecutive Quarter of Same-Store Transaction Growth

Social

Feb 7, 2025

NetEase to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 20

HANGZHOU,China,Feb. 6,2025-- NetEase,Inc. (NASDAQ: NTES and HKEX: 9999,"NetEase" or the "Company"),a leading internet and game services provider,today announced that it will report

Social

Feb 7, 2025

KT&G Successfully Improves Profitability in First Year of New Leadership, Promises Active Shareholder Returns

New CEO\'s fundamental competitiveness improvement and financial structure optimization leads to parallel growth of full-year revenue and operating profit

Social

Feb 7, 2025

1 ... 86 87 88 89 90 91 92 ... 123